These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2701778)

  • 1. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 2. [Functional brain study by radionuclide neuroimaging].
    Uemura K
    No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J; Itoh M; Matsuzawa T
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional imaging in dementia: an overview.
    Jagust WJ
    J Clin Psychiatry; 1994 Nov; 55 Suppl():5-11. PubMed ID: 7989292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.
    Weinstein HC; Scheltens P; Hijdra A; van Royen EA
    Clin Neurol Neurosurg; 1993 Jun; 95(2):81-91. PubMed ID: 8344019
    [No Abstract]   [Full Text] [Related]  

  • 7. [F-18 FDG PET in dementia].
    Ichiya Y
    Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of cerebral glucose utilization in dementia.
    Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
    González RG; Fischman AJ; Guimaraes AR; Carr CA; Stern CE; Halpern EF; Growdon JH; Rosen BR
    AJNR Am J Neuroradiol; 1995 Oct; 16(9):1763-70. PubMed ID: 8693972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of blood flow on the positron-emission tomographic determination of substrate transport rates.
    Holden JE
    Circulation; 1985 Nov; 72(5 Pt 2):IV72-6. PubMed ID: 3876895
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain glucose metabolism in Parkinson's disease.
    Metter EJ; Kuhl DE; Riege WH
    Adv Neurol; 1990; 53():135-9. PubMed ID: 2239454
    [No Abstract]   [Full Text] [Related]  

  • 12. Positron emission tomography and histopathology in Pick's disease.
    Kamo H; McGeer PL; Harrop R; McGeer EG; Calne DB; Martin WR; Pate BD
    Neurology; 1987 Mar; 37(3):439-45. PubMed ID: 3493451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emission computed tomography in the study of human epilepsy.
    Kuhl DE; Engel J; Phelps ME
    Res Publ Assoc Res Nerv Ment Dis; 1983; 61():327-40. PubMed ID: 6601815
    [No Abstract]   [Full Text] [Related]  

  • 14. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE; Metter EJ; Riege WH; Hawkins RA
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Positron emission tomography (PET) in the study of senile dementia].
    Terashi A
    Rinsho Shinkeigaku; 1986 Dec; 26(12):1302-5. PubMed ID: 3493871
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of brain metabolic abnormalities following treatment of AIDS dementia complex with 3'-azido-2',3'-dideoxythymidine (AZT, zidovudine): a PET-FDG study.
    Brunetti A; Berg G; Di Chiro G; Cohen RM; Yarchoan R; Pizzo PA; Broder S; Eddy J; Fulham MJ; Finn RD
    J Nucl Med; 1989 May; 30(5):581-90. PubMed ID: 2785582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography as an imaging tool in psychiatric disorders.
    Heiss WD; Pawlik G; Herholz K; Szelies B; Wienhard K
    Psychiatry Res; 1989 Sep; 29(3):351-2. PubMed ID: 2532752
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography.
    Alavi A; Reivich M; Ferris S; Christman D; Fowler J; MacGregor R; Farkas T; Greenberg J; Dann R; Wolf A
    Exp Brain Res; 1982; Suppl 5():187-95. PubMed ID: 6983979
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional cerebral glucose metabolism in patients with Parkinson's disease with or without dementia.
    Sasaki M; Ichiya Y; Hosokawa S; Otsuka M; Kuwabara Y; Fukumura T; Kato M; Goto I; Masuda K
    Ann Nucl Med; 1992 Nov; 6(4):241-6. PubMed ID: 1489634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic pathology of the AIDS dementia complex.
    Rottenberg DA; Moeller JR; Strother SC; Sidtis JJ; Navia BA; Dhawan V; Ginos JZ; Price RW
    Ann Neurol; 1987 Dec; 22(6):700-6. PubMed ID: 3501695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.